nektar therapeutics (NKTR:NASDAQ GS)
Paul Scigalla M.D.
Member of Oncology Advisory Committee, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 28 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Paul Scigalla MD serves as Member of Oncology Advisory Committee of Nektar Therapeutics. Paul Scigalla is President, Pharma Research Consulting, Switzerland. Paul is an Oncology Drug Developer.
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director and Member of Strategic Operations Committee|
Emergent BioSolutions, Inc.
|$1.0M||Compensation as of Fiscal Year 2013.|